Quality indicators for Palliative Day Services:A modified Delphi study by McCorry, Noleen K. et al.
                          McCorry, N. K., O'Connor, S., Leemans, K., Coast, J., Donnelly, M.,
Finucane, A., ... Dempster, M. (2019). Quality indicators for Palliative Day
Services: A modified Delphi study. Palliative Medicine, 33(2), 197-205.
https://doi.org/10.1177/0269216318810601
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1177/0269216318810601
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Sage
athttps://journals.sagepub.com/doi/10.1177/0269216318810601 . Please refer to any applicable terms of use of
the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
https://doi.org/10.1177/0269216318810601
Palliative Medicine
 1 –9
© The Author(s) 2018
Article reuse guidelines: 
sagepub.com/journals-permissions
DOI: 10.1177/026921631881060
journals.sagepub.com/home/pmj
What is already known about the topic?
•• Measurement of healthcare quality creates the basis for quality improvement.
•• Quality indicators can provide a valid and reliable means of measuring quality of care.
•• There are currently no published quality indicators specifically for Palliative Day Services.
What this paper adds?
•• This paper describes the development of the first set of quality indicators specifically for quality improvement in 
Palliative Day Services.
•• The final set comprises 7 structural indicators (e.g. ‘Service has a written standard operating procedure for development 
and use of multidisciplinary care plans’), 21 process indicators (e.g. ‘Proportion of service users with assessment of pain 
severity at screening using a valid measure’) and 2 outcome indicators (e.g. ‘Proportion of service users re-assessed at 
regular review who report that main care goals are met’).
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Abstract
Background: The goal of Palliative Day Services is to provide holistic care that contributes to the quality of life of people with life-
threatening illness and their families. Quality indicators provide a means by which to describe, monitor and evaluate the quality of 
Palliative Day Services provision and act as a starting point for quality improvement. However, currently, there are no published 
quality indicators for Palliative Day Services.
Aim: To develop and provide the first set of quality indicators that describe and evaluate the quality of Palliative Day Services.
Design and setting: A modified Delphi technique was used to combine best available research evidence derived from a systematic 
scoping review with multidisciplinary expert appraisal of the appropriateness and feasibility of candidate indicators. The resulting 
indicators were compiled into ‘toolkit’ and tested in five UK Palliative Day Service settings.
Results: A panel of experts independently reviewed evidence summaries for 182 candidate indicators and provided ratings on 
appropriateness, followed by a panel discussion and further independent ratings of appropriateness, feasibility and necessity. This 
exercise resulted in the identification of 30 indicators which were used in practice testing. The final indicator set comprised 7 structural 
indicators, 21 process indicators and 2 outcome indicators.
Conclusion: The indicators fulfil a previously unmet need among Palliative Day Service providers by delivering an appropriate and 
feasible means to assess, review, and communicate the quality of care, and to identify areas for quality improvement.
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Implications for practice, theory or policy
•• The quality indicator set offers day service providers with a means of describing and reviewing the quality of their care, 
and providing feedback to stakeholders.
•• Use of the indicator set in practice will allow providers to identify areas for quality improvement.
Introduction
Quality indicators are statements that define explicitly 
and in measurable terms the quality of a given construct 
or phenomenon. They provide a means with which to 
describe, monitor and evaluate healthcare.1 Ideally, they 
should be evidence-based with a theoretical foundation 
such as Donabedian’s2 structure, processes and outcomes 
framework. Quality indicators can provide service users, 
their families, care staff, providers, commissioners, pur-
chasers and inspectorates of care with data in relation to 
the quality of care, sometimes against benchmarks or pre-
vious quality assessments. In addition, by providing a valid 
and reliable means of measuring quality of care, quality 
indicators (although not sufficient by themselves) can act 
as a starting point for quality improvement.3
In the United Kingdom, as in many European countries, 
Palliative Day Services provide specialist palliative care 
within a group context for people with terminal or life-
limiting illness, facilitated by a specialist multidisciplinary 
team.4 The goal of Palliative Day Services is to provide 
individualised, holistic care that promotes independence 
and rehabilitation, improves self-worth and ultimately 
enables the best quality of life for patients and their fami-
lies.4,5 However, there is considerable variation within 
Palliative Day Services, and providers are under pressure 
to define and measure the quality of their services, iden-
tify areas for improvement and assess the impact of ser-
vice development and improvement efforts. In order to 
address these issues, we developed the first set of quality 
indicators that are designed specifically for use by 
Palliative Day Services. We propose that our indicators be 
used to support services to evaluate care quality on an 
ongoing basis, to identify valid and appropriate goals for 
quality improvement.
Methods and results
We used the Research ANd Development/University of 
California, Los Angeles (RAND/UCLA) appropriateness 
method6 which has been incorporated into a comprehen-
sive approach for the development of quality indicators in 
palliative care.7 The RAND/UCLA appropriateness method 
(RAM) is a modified Delphi method which combines the 
use of evidence with the collective judgement of experts 
and is particularly suited to this area of healthcare because 
of the dearth of evidence related to day services. Expert 
panellists provide two rounds of independent ratings and 
have the opportunity to discuss their judgements between 
the rating rounds during a face-to-face meeting. The 
method has been shown to have a high level of reproduc-
ibility and validity.6 Figure 1 shows the phases in the 
research process.
The study protocol was approved by the Research 
Ethics Committee, School of Psychology, Queen’s 
University Belfast (ref: 10-2015-16) in September 2015. 
Expert panel members provided written informed con-
sent to participate in the study.
Phase 1 - a systematic scoping review to 
identify existing quality indicators and 
domains
A systematic scoping review was conducted to identify exist-
ing quality indicators in all areas of palliative care and other 
evidence or recommendations which might inform the 
development of (or translation of evidence into) a quality 
indicator, that is, structural or process-level variables which 
have been shown to be related to the outcomes of care. Any 
domains/themes used to describe the indicators were also 
identified. Established frameworks were used to guide the 
review protocol,8,9 which is published elsewhere.10
This review resulted in the identification of 182 unique 
candidate indicators (supplementary file 1) and 17 care 
domains. Evidence tables summarising the content, sources 
and quality of evidence (using AIRE (Assessment of 
Indicators through Research and Evaluation) Instrument11 
and GRADE (Grading of Recommendations, Assessment, 
Development and Evaluations)12 scores where appropriate) 
of quality indicators represented in each domain were 
compiled.
Phase 2 - quality indicator selection 
by expert consultation following the 
internationally validated RAM
Round 1 - expert panel questionnaire. A multidisciplinary 
panel of individuals with expertise in Palliative Day Ser-
vices was established. A total of 58 potential panel mem-
bers were directly approached (recommended by the 
research team) or responded to advertisements. We 
selected experts based on their experience and expertise 
in the area of Palliative Day Services, while aiming for 
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diversity in geographical representation and professional 
specialism. Panel members were asked to commit 21 h to 
the project over 3 months. The resultant panel consisted 
of 21 individuals from across the United Kingdom, includ-
ing palliative care consultants, specialist nurses, day ser-
vice and hospice managers, allied health professionals, 
spiritual care providers, a social worker, a complemen-
tary therapist, a psychologist and a pharmacist. Several 
panellists had experience of more than 1 day of service 
model and previous experience of consensus develop-
ment methods. Panel members were sent a document 
pack including general information about quality indica-
tors and their properties (including a description of Don-
abedian’s2 model), a series of evidence tables for 
candidate quality indicators, a rating booklet and a short 
commentary from Marie Curie (a major UK palliative care 
provider) endorsing the project objectives. All materials 
were reviewed by the research team and two user 
representatives.
Panellists were asked to independently rate the appro-
priateness of each quality indicator on a 9-point scale 
(according to the RAM6) where an appropriate indicator 
(rated 7–9) was defined as one which was acceptable and 
likely to represent a reasonable measure of quality in 
Palliative Day Services. Alternatively, an inappropriate 
indicator (rated 1–3) was defined as one which should 
rarely or never be used as a measure of quality in Palliative 
Day Services, and where any re-wording or reframing of 
the indicator would not alter this assessment. Ratings of 
4–6 represented indicators which were thought to be nei-
ther appropriate nor inappropriate. Panellists were asked 
to base ratings on their own knowledge and experience, 
as well as the evidence summary tables provided, but not 
to rate appropriateness based on the cost implications 
associated with a particular indicator. It was explained to 
panellists that although cost consideration is an important 
factor in deciding whether a particular procedure or treat-
ment is ultimately made available to patients, the RAM 
Figure 1. Phases in the research process, including number of potential quality indicators identified at each stage.
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focuses only on the initial question of whether it is effec-
tive. Panellists were also asked to suggest additional qual-
ity indicators, and to review and provide feedback on the 
proposed quality domains. The indicator ratings were sub-
sequently analysed based on their median appropriate-
ness scores and the level of agreement between panel 
members using the criteria specified by the RAM.6 
Indicators with a median appropriateness rating of 3 or 
less (inappropriate) and good agreement on this rating by 
the panel were highlighted for exclusion.
Twenty panellists returned round 1 ratings. Round 1 
resulted in the identification of 70 inappropriate indica-
tors and 112 candidate appropriate or uncertain 
indicators.
Round 2 - expert panel meeting. All panellists who partici-
pated in round 1 were invited to attend a 1-day, face-to-
face meeting, where the analysis of round 1 ratings was 
presented. The meeting was moderated by a health psy-
chologist (M.De.) with extensive experience in facilitating 
group discussion and was attended by 12 panellists. The 
aims of the meeting were as follows:
1. Confirm the exclusion of indicators rated as inap-
propriate as a result of round 1 ratings;
2. Discuss those indicators for which, following round 
1, appropriateness was uncertain;
3. Discuss indicators for which appropriateness was 
acceptable but there was disagreement between 
panellists;
4. Review the terminology used in indicator 
descriptions.
Following the discussions, panellists were asked to 
independently re-rate the appropriateness of the 112 
indicators. Panel members agreed that the indicator set 
should be designed and promoted as a tool to support the 
assessment of quality in a formative manner, and the 
identification of quality improvement goals, and not as a 
means of comparison between services or for inspection 
purposes – which would require more detailed considera-
tion of risk adjustments. At this stage, panel members 
were also asked to independently rate the feasibility of 
measuring each indicator in the day service setting using 
the same 9-point scale and to assess if each indicator was 
a necessary measure (yes/no response). A necessary 
measure was defined as follows: appropriate; likely to 
benefit the patient; that the benefit is not small; and 
where it would be improper care not to offer the proce-
dure under review.6 The same criteria as round 1 were 
used to remove inappropriate indicators. In addition, only 
quality indicators with a median feasibility rating of 4 or 
greater (with good agreement) were retained. The cate-
gorisation of necessity was used to produce a list of core 
and supplementary indicators. Indicators were defined as 
supplementary if less than half the panel identified the 
indicators as a necessary measure.
As a result of round 2 ratings, 11 indicators were agreed 
to be inappropriate and 17 were unfeasible. A further 28 
indicators were removed based on the assessment of 
necessity. Hence, 56 core indicators (agreed to be appro-
priate, feasible and necessary) were retained following 
round 2. Supplementary file 1 shows the decisions during 
rounds 1 and 2.
Round 3 - second panel questionnaire. The set of 56 core 
indicators was then reviewed by the research team and 
expert panel members (with a particular focus on wording 
and duplication) who were sent the indicator set by email.
Round 3 resulted in the re-wording or combination of 
41 indicators, and hence a consolidated set of 30 unique 
indicators. Supplementary file 2 shows the derivation of 
the draft indicator set from the original 182 candidate 
indicators. This draft indicator set included 7 structural 
indicators, 21 process indicators and 2 outcome indica-
tors, categorised under 10 domains of care. There were 
most quality indicators (n = 9) representing the domain 
‘co-ordination and continuity of care’. For 24 of the indica-
tors, the focus is on patient or staff interaction with the 
service (e.g. ‘Proportion of service users with assessment 
of pain severity at screening using a valid measure’ (#A1)), 
while 6 indicators represented service characteristics (e.g. 
‘Service has a written care pathway for assessment and 
management of moderate or severe pain including appro-
priate onward referral routes’ (#E12)).
Phase 3 - testing the draft quality indicator 
set in practice
The draft indicator set was compiled into a toolkit with 
detailed descriptions of each quality indicator (including 
the numerator, denominator and definitions) and 
instructions to assist with the extraction of relevant 
data. Supplementary file 3 is an extract from the toolkit. 
The indicator set and toolkit were then field tested in 
five UK Palliative Day Service settings, in England (2), 
Scotland (1) and Northern Ireland (2) representing three 
different palliative care providers. The toolkit instructed 
data abstractors to assess performance on each quality 
indicator using paper-based or electronic records for 15 
consecutive patients discharged from the Palliative Day 
Service in the previous 12 months (for patient-level indi-
cators) and any relevant accessible documentation 
including service policies and procedures (for service-
level indicators). Day service managers at each site com-
pleted the data abstraction. Abstractors were asked to 
‘think aloud’13 while completing the paperwork – so that 
challenges or misunderstandings could be readily identi-
fied by the researcher, who was available during the 
entire abstraction process.
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In total, data were extracted from 82 patient records. 
Following completion of the practice test, the rate and 
variation in the proportion of patients/staff for whom 
each quality indicator was met and the proportion of set-
tings which satisfied the service-level indicators were 
compiled (supplementary file 4). Overall, there was con-
siderable variation across the five services in performance 
against the indicators, particularly for assessment of 
patient satisfaction, recording of care goals and comple-
tion of care plans. The indicators that were least likely to 
be met were concerned with quality-of-life assessment, 
availability of a completed multidisciplinary care plan and 
assessment of patient satisfaction with support for deci-
sion-making, with some services not collecting any infor-
mation on patient satisfaction or quality of life. The 
indicators that were most likely to be met were concerned 
with the documentation of time from referral to first 
attendance date offered; informed consent to treatment 
or medical intervention; and communication between the 
service and the general practitioner providing information 
on care needs and care plans. Feedback from data abstrac-
tors indicated the following:
•• Data abstraction was perceived as time- 
consuming;
•• Abstractors had to refer to several different sources 
of information;
•• The paper-based extraction forms added to the 
cumbersome nature of the process;
•• Data abstractors were not confident about the pro-
cess for calculation of each indicator.
As a result of the practice test, minor amendments 
were made to three of the indicators and to the toolkit 
instructions. Table 1 shows the final (QualPalUK) quality 
indicator set.
Discussion
Results of the study
We have developed the first set of quality indicators specifi-
cally for use in Palliative Day Services, using a recommended, 
evidence-based approach.7 The indicators were derived 
from a comprehensive review of the international literature. 
The full set of original 182 indicators is provided as a 
resource in supplementary material and can be used to 
make adjustments for jurisdictions outside the United 
Kingdom if necessary. The final indicator set (reflecting 
Donabedian’s2 model) contains 2 outcome, 21 process and 
7 structural indicators, across 10 domains of care. The lim-
ited number of outcome indicators is a result of the expert 
panel’s preference to incorporate patient-reported outcome 
measurement (in relation to the assessment of pain, breath-
lessness, fatigue, functional status, depression, anxiety and 
quality of life) into relevant process and structural indica-
tors, and to avoid the complex adjustment and exclusions 
often associated with the quality appraisal using outcome 
indicators.14–19 For example, rather than measure absolute 
‘pain intensity’ or ‘change in pain intensity’ (both outcome 
indicators), the panel preferred to measure the extent to 
which patients had their pain measured using a validated 
instrument (#A1 and #A2 - both process indicators) and the 
extent to which valid pathways were in place to manage the 
individual patient’s pain (#E12 - a structural indicator). This 
approach still incorporates the perspective of the service 
user in the process of quality assessment,20,21 but requires 
that staff solicit these patient-reported outcomes routinely 
and use them effectively to meet patient needs. Clearly, 
however, both structural and process-level quality indica-
tors are only valid assessments of quality of care if they can 
be shown to increase the likelihood of a good outcome,22 
and hence, the evidence base should be reviewed regularly 
to identify these relationships. The panel did, however, 
endorse outcome indicators in relation to service users’ sat-
isfaction with information and advice received (#D10) and 
whether service users reported that their main care goals 
had been met (#G23).
One characteristic of a ‘good quality indicator’ is the 
extent to which the quality indicator refers to an aspect 
of care which can be influenced by the players being eval-
uated.23 Many quality indicators developed more 
recently7,24–26 have been proposed to be relevant to a 
range of different palliative care services. It is inevitable 
though that some of the indicators within these sets will 
not be within the control of those care personnel associ-
ated with the service being evaluated. Several authors 
have commented on this ‘fit’ between the indicator set 
and the service being evaluated27,28 and have recom-
mended that indicators be amended or removed as 
appropriate. We believe that the specificity of our indica-
tor set is a significant advantage as it means the indicator 
set is immediately accessible to UK Palliative Day Services, 
without modification. There is considerable scope for 
international collaboration in the development of quality 
indicators,29,30 and hence, with appropriate modifications 
to account for contextual and cultural differences, our 
indicator set will be valuable in other Palliative Day 
Services, internationally. The original set of 182 unique 
Palliative Day Services quality indicators (supplementary 
file 2) derived from a comprehensive review of the inter-
national literature is a valuable reference for other provid-
ers wishing to develop Palliative Day Services quality 
indicators.
Implementation in practice
The value of quality indicators is fully realised when they 
are implemented in routine practice and used as a basis 
for quality improvement. Fifteen years after the Council of 
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Table 1. Final QualPalUK quality indicator set (n = 30), following phase 3 of the RAND/UCLA appropriateness method.
Indicator description, categorised by care domain Indicator 
type
A Physical care and support, assessment and treatment
A1 Proportion of service users with assessment of pain severity at screening using a valid measure P
A2 Proportion of service users with moderate or severe pain assessed to explore possible causes of pain P
A3 Proportion of service users with assessment of breathlessness at screening using a valid measure P
A4 Proportion of service users with assessment of fatigue at screening using a valid measure P
A5 Proportion of service users with assessment of functional status to identify daily activity limitations completed 
before a multidisciplinary care plan
P
B Psychological care and support, assessment and treatment
B6 Proportion of service users screened for depression at screening using a valid measure P
B7 Proportion of service users screened for anxiety at screening using a valid measure P
B8 Proportion of service users with assessment of cognitive functioning P
C Spiritual and emotional care and support
C9 Proportion of service users with documentation of a ‘spiritual aspects of care discussion or assessment’ 
completed before a multidisciplinary care plan
P
D Information and communication with service users
D10 Proportion of service users who report that they are provided with sufficient, appropriately tailored information 
or advice on their condition and on intervention options to support decisions on agreed care planning
O
E Co-ordination and continuity of care
E11 Proportion of service users with a comprehensive needs assessment completed before a multidisciplinary care 
plan to identify main symptoms and concerns, and their effect
P
E12 Service has a written care pathway for assessment and management of moderate or severe pain including 
appropriate onward referral routes
S
E13 Proportion of service users with documentation of re-assessment at regular review in line with time points 
agreed in the multidisciplinary care plan
P
E14 Service has written standard operating procedures defining timeframes for time to initial contact, completion of 
needs assessment and multidisciplinary care plan
S
E15 Proportion of service users with documentation of appropriate intervention in line with the agreed, 
multidisciplinary care plan
P
E16 Proportion of service users with documented communication between the service and the general practitioner 
providing information on care needs and care plans
P
E17 Proportion of service users with a care plan available as specified by the service’s written standard operating 
procedure for development and usage of multidisciplinary care plans
P
E18 Proportion of service users with documented evidence of being offered the opportunity for completion of 
advance care planning
P
E19 Proportion of service users with quality of life assessed using a valid measure at screening and at regular review 
in line with time points agreed in the multidisciplinary care plan
P
F Care planning, goal setting and shared decision-making with service users
F20 Service has a written standard operating procedure for development and use of multidisciplinary care plans S
F21 Proportion of service users with documentation of main care goals in the multidisciplinary care plan P
G Evidence of effectiveness, outcome assessment and measurement
G22 Service has a written policy for reviewing and updating standard operating procedures and care pathways S
G23 Proportion of service users re-assessed at regular review who report that main care goals are met in line with 
the multidisciplinary care plan
O
G24 Proportion of service users with assessment of satisfaction with overall care and support performed using a 
valid measure
P
G25 Proportion of service users with assessment of satisfaction with involvement in shared decision-making P
H Staff training and education, service and professional development
H26 Extent to which staff have access to training around core components of care as part of continuing education 
and personal development
S
I Access to services and service environment
I27 Proportion of service users with a record of time in days from referral date to first attendance date offered by service P
I28 The service provides suitable equipment and settings to deliver care S
I29 Service has a written policy for defining standards for equipment and settings which are available for delivery of care S
J Societal, ethical and legal aspects of care
J30 Proportion of service users with correctly completed documentation of informed consent to treatment or 
medical intervention
P
RAND/UCLA: Research ANd Development/University of California, Los Angeles; S: structure; P: process; O: outcome.
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Europe first encouraged the definition and adoption of 
quality indicators of good palliative care, there is still little 
evidence of widespread implementation in practice.16,31,32 
Some of the barriers to successful implementation of 
quality indicators in palliative care settings include the 
attitudes towards quality improvement within the organi-
sation27 and among staff,28 the perceived value of quality 
indicators27,28 and ‘top-down’ engagement.27 Drawing 
upon this evidence and the improvement science litera-
ture,33 we have incorporated features in our research 
design which are intended to improve the likelihood of 
uptake and implementation by Palliative Day Services. 
Use of the rigorous RAM results in a set of indicators with 
high face and content validity.34–36 We have enhanced the 
perceived acceptability and credibility of the indicator set 
by promoting stakeholder awareness and involvement in 
the development of the indicators, and by ensuring repre-
sentation on our expert panel from services where we 
wish the indicators to be utilised. We have communicated 
widely (via newsletters, presentations, the QualPalUK 
website and site visits) about the development process 
and have provided opportunities for stakeholder feed-
back. However, for successful implementation, we will 
also need to be attuned to variations in current practice, 
the range of measures already in place in care settings, 
the diversity of systems (including IT systems) and staff 
training.28,37
Assessment of care quality is agreed to be an essential 
element of service provision, and the quality indicator set 
is a comprehensive and evidence-based tool that enables 
this process. This comprehensive assessment requires 
time investment by services that are often time-poor, on 
an annual or bi-annual basis. Implementation will be facil-
itated where services are able to organise their routinely 
collected data in a manner that is easily accessible for 
data extractors; service personnel recognise the direct 
impact of quality assessment on service improvements; 
data extractors become more familiar with use of the 
tool; and where efficiency of data extraction is enhanced 
via electronic capture. We are now developing an elec-
tronic version of the quality indicator toolkit which will 
help to reduce the time required for data extraction and 
calculation of the quality indicators by allowing abstrac-
tors to input the required (prompted) fields, with calcula-
tions completed by the programme in the background. 
We will supplement the quality indicator toolkit with a 
quality improvement module which will support Palliative 
Day Services to first identify areas for quality improve-
ment and subsequently to use Plan-Do-Study-Act cycles38 
to work towards improvement.
Although there were only five practice sites, the practice 
test indicated that the assessment of satisfaction and qual-
ity of life, and the production (and communication of) com-
prehensive care plans and needs assessments are areas 
which may require attention within Palliative Day Services. 
This finding is consistent with existing literature which has 
demonstrated that, despite initiatives promoting the rou-
tine measurement of patient-reported outcomes39–42 and 
strong evidence of a positive effect on a multitude of care 
outcomes (including patient-clinician communication, 
patient satisfaction and identification of unrecognised 
symptoms),43 they are not yet widely measured in palliative 
care practice. Failure to implement patient-reported out-
come measurement in palliative care has been attributed 
to barriers including fear of change, time management/ 
constraints, lack of education on use of tools, burden of 
tools for staff and service users, illness severity, concerns 
about criticism and cost constraints.44 The assessment of 
patient-reported outcomes is therefore one area where 
quality improvement projects may be particularly produc-
tive and valued by the Palliative Day Services community. In 
contrast, indicators which utilise administrative data that 
map onto the requirements of national45 or internal organi-
sational audits were more likely to be met, such as ‘time 
from referral to first attendance’ or ‘consent to treatment’.
Strengths and weaknesses
The RAM has been shown to produce indicators with high 
content34,46 and predictive validity.32,47,48 However, these 
characteristics and others (including sensitivity to change 
and reliability) should be field tested in a larger represent-
ative sample of Palliative Day Services, using the elec-
tronic toolkit for data extraction. In addition, the time 
commitment required from Delphi panellists often results 
in a panel that is atypical with respect to their interest and 
commitment to the topic being investigated. Generating 
interest in the value and implementation of Palliative Day 
Services quality indicators more widely is likely to be 
challenging.
What this study adds
Our quality indicator set fulfils a need within the Palliative 
Day Services community, by providing a means of assess-
ing and reviewing quality of care, and identifying areas for 
improvement.
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